L. Thevanayagam

Pharmacokinetic characterization of BMS‐936561, an anti‐CD70 antibody‐drug conjugate, in preclinical animal species and prediction of its pharmacokinetics in humans

P. Marathe, M. Srinivasan, P. Cardarelli, 2016, Biopharmaceutics & drug disposition.

Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions

T. Blaschke, F. Aweeka, A. Jayewardene, 2006, HIV medicine.

Fucosyl Monosialoganglioside: Quantitative analysis of specific potential biomarkers of lung cancer in biological matrices using immunocapture extraction/tandem mass spectrometry.

T. Olah, M. Srinivasan, J. Hogan, 2018, Rapid communications in mass spectrometry : RCM.

Altered Pharmacokinetics of Indinavir by a Novel Nonnucleoside Reverse Transcriptase Inhibitor (HBY‐097): A Pharmacokinetic Evaluation in HIV‐Positive Patients

S. Hayashi, F. Aweeka, A. Shah, 1999, Journal of clinical pharmacology.

Comparison of zidovudine phosphorylation in lymph nodes and peripheral blood mononuclear cells in HIV-infected patients. DATRI 012 Study Group.

J. Pearl, J. Lalezari, J. Gambertoglio, 1998, AIDS.

Novel detection of DNA-alkylated adducts of antibody-drug conjugates with potentially unique preclinical and biomarker applications.

Zemin Wang, A. Bell, M. Srinivasan, 2013, Bioanalysis.

The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudine

J. Aberg, F. Aweeka, S. Rosenkranz, 2006, AIDS.

The stability of intracellular zidovudine and its anabolites in extracts of peripheral blood mononuclear cells (PBMCs).

J. Gambertoglio, A. Jayewardene, L. Thevanayagam, 2000, Journal of pharmaceutical and biomedical analysis.

Design, synthesis and biological evaluation of phenol-linked uncialamycin antibody-drug conjugates.

A. Mathur, G. Vite, Y. Poudel, 2019, Bioorganic & medicinal chemistry letters.